Atlas Trials

reMYND

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch reMYND

RecordFirmDate
A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants. (NCT07016464)reMYND2025-03-20
A Phase 1 (First in Human) Randomized, Double-blind, Placebo-controlled SAD, MAD Study With Oral REM0046127 (NCT04672135)reMYND2020-11-09

Track reMYND automatically

Every clearance here is in the API, with alerts when new ones post.